513 related articles for article (PubMed ID: 26372964)
1. Phospholipid dysregulation contributes to ApoE4-associated cognitive deficits in Alzheimer's disease pathogenesis.
Zhu L; Zhong M; Elder GA; Sano M; Holtzman DM; Gandy S; Cardozo C; Haroutunian V; Robakis NK; Cai D
Proc Natl Acad Sci U S A; 2015 Sep; 112(38):11965-70. PubMed ID: 26372964
[TBL] [Abstract][Full Text] [Related]
2. ApoE4-associated phospholipid dysregulation contributes to development of Tau hyper-phosphorylation after traumatic brain injury.
Cao J; Gaamouch FE; Meabon JS; Meeker KD; Zhu L; Zhong MB; Bendik J; Elder G; Jing P; Xia J; Luo W; Cook DG; Cai D
Sci Rep; 2017 Sep; 7(1):11372. PubMed ID: 28900205
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-195 rescues ApoE4-induced cognitive deficits and lysosomal defects in Alzheimer's disease pathogenesis.
Cao J; Huang M; Guo L; Zhu L; Hou J; Zhang L; Pero A; Ng S; El Gaamouch F; Elder G; Sano M; Goate A; Tcw J; Haroutunian V; Zhang B; Cai D
Mol Psychiatry; 2021 Sep; 26(9):4687-4701. PubMed ID: 32632205
[TBL] [Abstract][Full Text] [Related]
4. Roles of apolipoprotein E4 (ApoE4) in the pathogenesis of Alzheimer's disease: lessons from ApoE mouse models.
Huang Y
Biochem Soc Trans; 2011 Aug; 39(4):924-32. PubMed ID: 21787325
[TBL] [Abstract][Full Text] [Related]
5. Gene-environment interaction between lead and Apolipoprotein E4 causes cognitive behavior deficits in mice.
Engstrom AK; Snyder JM; Maeda N; Xia Z
Mol Neurodegener; 2017 Feb; 12(1):14. PubMed ID: 28173832
[TBL] [Abstract][Full Text] [Related]
6. In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.
Tangwongchai S; Supasitthumrong T; Hemrunroj S; Tunvirachaisakul C; Chuchuen P; Houngngam N; Snabboon T; Tawankanjanachot I; Likitchareon Y; Phanthumchindad K; Maes M
Mol Neurobiol; 2018 Aug; 55(8):6449-6462. PubMed ID: 29307083
[TBL] [Abstract][Full Text] [Related]
7. Identification and modification of amyloid-independent phenotypes of APOE4 mice.
DiBattista AM; Dumanis SB; Newman J; Rebeck GW
Exp Neurol; 2016 Jun; 280():97-105. PubMed ID: 27085394
[TBL] [Abstract][Full Text] [Related]
8. Human apolipoprotein E4 modulates the expression of Pin1, Sirtuin 1, and Presenilin 1 in brain regions of targeted replacement apoE mice.
Lattanzio F; Carboni L; Carretta D; Rimondini R; Candeletti S; Romualdi P
Neuroscience; 2014 Jan; 256():360-9. PubMed ID: 24161275
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E4 Causes Age-Dependent Disruption of Slow Gamma Oscillations during Hippocampal Sharp-Wave Ripples.
Gillespie AK; Jones EA; Lin YH; Karlsson MP; Kay K; Yoon SY; Tong LM; Nova P; Carr JS; Frank LM; Huang Y
Neuron; 2016 May; 90(4):740-51. PubMed ID: 27161522
[TBL] [Abstract][Full Text] [Related]
10. The Effects of Gene-Environment Interactions Between Cadmium Exposure and Apolipoprotein E4 on Memory in a Mouse Model of Alzheimer's Disease.
Zhang L; Wang H; Abel GM; Storm DR; Xia Z
Toxicol Sci; 2020 Jan; 173(1):189-201. PubMed ID: 31626305
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E4 causes age- and sex-dependent impairments of hilar GABAergic interneurons and learning and memory deficits in mice.
Leung L; Andrews-Zwilling Y; Yoon SY; Jain S; Ring K; Dai J; Wang MM; Tong L; Walker D; Huang Y
PLoS One; 2012; 7(12):e53569. PubMed ID: 23300939
[TBL] [Abstract][Full Text] [Related]
12. Understanding the basis for the association of apoE4 with Alzheimer's disease: opening the door for therapeutic approaches.
Zhong N; Weisgraber KH
Curr Alzheimer Res; 2009 Oct; 6(5):415-8. PubMed ID: 19874264
[TBL] [Abstract][Full Text] [Related]
13. PKR Inhibition Rescues Memory Deficit and ATF4 Overexpression in ApoE ε4 Human Replacement Mice.
Segev Y; Barrera I; Ounallah-Saad H; Wibrand K; Sporild I; Livne A; Rosenberg T; David O; Mints M; Bramham CR; Rosenblum K
J Neurosci; 2015 Sep; 35(38):12986-93. PubMed ID: 26400930
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E4 domain interaction: synaptic and cognitive deficits in mice.
Zhong N; Scearce-Levie K; Ramaswamy G; Weisgraber KH
Alzheimers Dement; 2008 May; 4(3):179-92. PubMed ID: 18631967
[TBL] [Abstract][Full Text] [Related]
15. Intraneuronal amyloid-beta plays a role in mediating the synergistic pathological effects of apoE4 and environmental stimulation.
Levi O; Dolev I; Belinson H; Michaelson DM
J Neurochem; 2007 Nov; 103(3):1031-40. PubMed ID: 17666042
[TBL] [Abstract][Full Text] [Related]
16. Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer's disease.
Halliday MR; Rege SV; Ma Q; Zhao Z; Miller CA; Winkler EA; Zlokovic BV
J Cereb Blood Flow Metab; 2016 Jan; 36(1):216-27. PubMed ID: 25757756
[TBL] [Abstract][Full Text] [Related]
17. The Synergistic Effects of APOE Genotype and Obesity on Alzheimer's Disease Risk.
Jones NS; Rebeck GW
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30586872
[TBL] [Abstract][Full Text] [Related]
18. Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2.
Vandal M; Alata W; Tremblay C; Rioux-Perreault C; Salem N; Calon F; Plourde M
J Neurochem; 2014 May; 129(3):516-26. PubMed ID: 24345162
[TBL] [Abstract][Full Text] [Related]
19. Inducible and Conditional Activation of Adult Neurogenesis Rescues Cadmium-Induced Hippocampus-Dependent Memory Deficits in ApoE4-KI Mice.
Matsushita MT; Wang H; Abel GM; Xia Z
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298071
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer disease: APOE*ε4-associated increase in AD risk linked to phospholipid dysregulation.
Malkki H
Nat Rev Neurol; 2015 Nov; 11(11):610. PubMed ID: 26416537
[No Abstract] [Full Text] [Related]
[Next] [New Search]
